Potential 3‐chymotrypsin‐like cysteine protease cleavage sites in the coronavirus polyproteins pp1a and pp1ab and their possible relevance to COVID‐19 vaccine and drug development-Reference-Cited by-同舟云学术

Potential 3‐chymotrypsin‐like cysteine protease cleavage sites in the coronavirus polyproteins pp1a and pp1ab and their possible relevance to COVID‐19 vaccine and drug development

Published:2021-04-29 Issue:5 Volume:35 Page:
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Yan Shaomin¹^ORCID,Wu Guang¹^ORCID

Affiliation:

1. National Engineering Research Center for Non‐Food Biorefinery, State Key Laboratory of Non‐Food Biomass and Enzyme Technology, Guangxi Biomass Engineering Technology Research Center, Guangxi Key Laboratory of Biorefinery Guangxi Academy of Sciences Nanning China

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.202100280RR

Reference96 articles.

1. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

2. Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases

3. Three-dimensional domain swapping as a mechanism to lock the active conformation in a super-active octamer of SARS-CoV main protease

4. Computational modeling of the bat HKU4 coronavirus 3CL pro inhibitors as a tool for the development of antivirals against the emerging M iddle E ast respiratory syndrome ( MERS ) coronavirus

5. Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An ISG15-Based High-Throughput Screening Assay for Identification and Characterization of SARS-CoV-2 Inhibitors Targeting Papain-like Protease;Viruses;2024-08-01

2. Therapeutic implications of quercetin and its derived-products in COVID-19 protection and prophylactic;Heliyon;2024-05

3. Peptidyl nitroalkene inhibitors of main protease rationalized by computational and crystallographic investigations as antivirals against SARS-CoV-2;Communications Chemistry;2024-01-18

4. Targeted degrader technologies as prospective SARS-CoV-2 therapies;Drug Discovery Today;2024-01

5. On the origins of SARS-CoV-2 main protease inhibitors;RSC Medicinal Chemistry;2024